4 + 7 to expand varieties! Famous drugstores join in the price war of price reduction?

Wen Linan The implementation of the first batch of procurement with volume, not only the price of 25 shortlisted varieties decreased significantly, but also the prices of other non evaluated and related original research drugs decreased Since December last year, the first batch of purchasing with volume has been more than one year The influence of belt purchase on the industry is far-reaching Recently, the industry has heard that a new round of belt purchase is coming, that is, the 4 + 7 expansion of varieties has begun The mode of 4 + 7 centralized mining is becoming more and more mature, and after one year, the scope of price reduction radiation is also broader On December 19, Shanghai organized the schedule outflow of the working conference on centralized drug purchase and use, which introduced the 4 + 7 pilot and expansion, as well as the discussion and signing of a new round of centralized procurement documents It is speculated that the procurement of new tires (4 + 7 varieties expansion) will be started at the earliest or around December 25, no later than January 20, with 35 varieties shortlisted, involving 61 specifications and 190 drugs On the same day, Hebei Province released a notice on the results of centralized procurement of drugs for outpatients of hypertension and diabetes in urban and rural residents There is no difference between the results and the results published on December 11 13 kinds of outpatient drugs for hypertension and diabetes were selected, of which 10 drugs were priced at several cents per tablet The following is the publication table of the selected results: Compared with the latest bid winning prices of the 13 selected varieties, the average decrease was 67.5%, among which the decrease of captopril group was the most, reaching 97.9%; the decrease of valsartan capsule of Yongxin pharmaceutical was the least, 11.7% The median price of nifedipine tablets in Luxi pharmaceutical industry is 0.0123 yuan (10mg), which is the lowest median price product It is worth noting that the final price of the 13 selected products is lower than the limit price, which means that a number of new national lowest prices have emerged The new round of centralized purchase is to expand varieties on the basis of 25 selected varieties in the first round of centralized purchase It is planned that 35 drugs will be selected Among them, metformin, acarbose and glimepiride are the same as those collected in Hebei Province Different from the national centralized purchase, Hebei centralized purchase includes drugs that fail to pass the consistency evaluation In September this year, the guidance on improving the mechanism of outpatient medication security for urban and rural residents with hypertension and diabetes mellitus (medical insurance Fa [2019] No 54) jointly issued by the State Medical Insurance Bureau, the Ministry of finance, the state health and Health Commission and the State Food and drug administration clearly mentioned that the payment standard of medical insurance for "two diseases" drugs should be reasonably determined according to the common name and adjusted dynamically We will actively promote the centralized procurement of drugs with quantity, and combine quantity with price, bidding and procurement For drugs included in the scope of procurement with quantity, the payment standard for drugs with the same generic name will be determined according to the bid winning price of centralized procurement Industry personage pointed out that at present, the reimbursement of medical insurance in China is based on the proportion of drug price Whether it is original research or imitation, it is based on the same proportion With the consistency evaluation and volume purchase promoting the import substitution of generic drugs, medical insurance will be inclined to generic drugs in the future and become more civilian Ping An Securities Analysis said that in the new payment standard for medical insurance, the bid price of generic drugs is expected to be the payment standard for medical insurance, which is reimbursed according to the proportion of the payment price for medical insurance, and after the price is exceeded, each person will bear the cost This trend is also reflected in the policy of adjusting the medical insurance catalogue The medical insurance bureau mentioned that during the validity period of the negotiated medical insurance drugs, if the same generic drugs (generic drugs) are listed, the medical insurance department will adjust the payment standard of the drugs according to the price level of generic drugs Previously, the opinions on the supporting measures for centralized drug procurement and use pilot medical insurance issued by the state health insurance bureau also mentioned that for non selected drugs whose price is more than twice the price of the selected drugs by the end of 2018, the payment standard is to reduce the original price by no less than 30% in 2019, and to adjust the payment standard to the price of the selected drugs in 2020 or 2021 For some drugs with large price difference from the selected drugs, the State Medical Security Bureau requires the pilot areas to gradually adjust the payment standard according to the principle of "step by step, classification guidance", and adjust it in place within 2-3 years Under the influence of the first batch of on-site procurement, the unselected varieties were removed from the network one after another due to various reasons From the above requirements, the time limit for adjustment is near At present, all regions are stepping up to guide the price reduction of drugs purchased in volume but not selected For example, on October 22 of this year, Liaoning issued the notice on carrying out the work of gradient price reduction for non selected drugs in centralized drug procurement in the alliance region The notice on price reduction for 4 + 7 non selected drugs in this province covers 310 drugs, including 169 other generic drugs It is also required to be lower than the price of the selected drugs, otherwise, it will also be disqualified from the network Pfizer, Sanofi, Zhengda Tianqing and other domestic and foreign knowledge A number of blockbuster drugs from famous pharmaceutical companies are listed On December 18, Gansu provincial drug centralized purchase platform announced the result of price reduction applied by the national organization drug centralized with quantity purchase alliance's medium-sized and non medium-sized drug manufacturers with the same generic name and the same product specification, among which 51 non selected varieties applied for price reduction actively; On December 6, Hainan public resources trading service center issued a notice saying that the price of the products with no objection was reduced, and the products without price reduction were removed from the network Of the 235 product specifications requiring gradient price reduction, 149 chose price reduction In the process of 4 + 7 pilot, there were different prices of the same drug between non pilot areas and pilot areas, hospitals and hospitals, hospitals and pharmacies Industry analysts believe that with the coming of 4 + 7 expansion and variety expansion, drugstores will also usher in the era of low gross profit In the process of 4 + 7 expansion, some provinces also explicitly proposed to encourage private medical institutions and retail pharmacies designated by medical insurance to actively participate By the end of 2019, many drugstores have begun to follow the trend For example, not long ago, shuyuminmin pharmacy announced that it would resolutely implement the policy of the National Health Insurance Bureau, and the chain drugstores could operate 22 centralized procurement products Since December this year, more than 1600 stores in shuyuminmin pharmacy across the province will uniformly implement the bid winning price of centralized procurement of drugs organized by the state On December 18, Yifeng pharmacy official micro issued an emergency notice saying: if the consumer purchases the same specification drugs of the same factory lower than the retail price or membership price of the store within 2 kilometers from other market institutions other than Yifeng Once verified, Yifeng will return 3 times the difference of the minimum selling unit price of the drug On December 20, the official and micro pharmacies of the common people's pharmacy also issued a notice: in addition to the 4 + 7 cities with volume purchasing, in order to benefit the common people, the common people's pharmacies in 22 provinces across the country, Hunan, Jiangsu, Gansu, Guangxi, Anhui, Zhejiang, Inner Mongolia, Hubei, Henan, Shandong, Hebei, Jiangxi, Ningxia, Fujian, Guizhou, Shanxi and other 5000 + stores across the country will synchronously implement the national volume purchasing bid Price Compared with the lowest purchase price of the same kind of drugs in 2018, the maximum reduction of the winning varieties is 90%, with an average decrease of 59%.